Dr. Delpassand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9701 Richmond Ave
Suite 122
Houston, TX 77042Phone+1 713-781-6200Fax+1 713-781-6206- Is this information wrong?
Education & Training
- Baylor College of MedicineResidency, Pathology-Anatomic and Clinical, 1990 - 1991
- Baylor College of MedicineResidency, Nuclear Medicine, 1988 - 1990
- Tehran University of Medical Sciences School of MedicineClass of 1982
Certifications & Licensure
- TX State Medical License 1990 - 2025
- OK State Medical License 1988 - 1992
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer Start of enrollment: 2005 Jun 01
- Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors Start of enrollment: 2005 Aug 01
- 177Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine Neoplasms Start of enrollment: 2010 Oct 27
- Join now to see all
Publications & Presentations
PubMed
- Alpha-emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor.Andrew Wahba, Rodolfo Nunez, Rouzbeh Esfandiari, Ebrahim S Delpassand, Rajkumar Venkatramani> ;Pediatric Blood & Cancer. 2024 Jun 1
- Effectiveness and Safety of Retreatment withLu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States.Soheil M Yazdi, Shashank Ghantoji, Antonio Nakasato, Corinne Strickland, Rodolfo Nunez, Afshin Shafie, Susan Cork, Clare Byrne, Jackson Tang, Jeetvan Patel, Ebrahim S ...> ;Journal of Nuclear Medicine. 2024 Mar 21
- 3 citationsToward Integrated Independence: Johannes Czernin Discusses the Future of Theranostics with Ebrahim Delpassand, Eric Rohren, and Wolfgang Weber.Ebrahim S Delpassand, Eric M Rohren, Wolfgang A Weber, Johannes Czernin> ;Journal of Nuclear Medicine. 2023 Sep 1
- Join now to see all
Press Mentions
- Right to Try Is Unleashing the Future of MedicineSeptember 13th, 2022
- Vect-Horus and RadioMedix Announce FDA Approval of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma MultiformeJuly 8th, 2021
- RadioMedix & Curium Announce Detectnetᵀᴹ (Copper Cu 64 Dotatate Injection) Inclusion on NCCN Guidelines®May 5th, 2021
- Join now to see all
Hospital Affiliations
- HCA Houston Healthcare WestHouston, Texas
- St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: